Archive for March 31st, 2010
Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety
FDA is reviewing data from a large, long-term clinical study on possible risks for cardiovascular outcomes associated with use of rosiglitazone, known as Avandia.
admin | Mar 31, 2010
Rotarix Vaccine: Update to Clinicians and Public Health Professionals
Recommendation to suspend use is a precaution while FDA learns more about the situation. No known safety risk at this time.
admin | Mar 31, 2010
Sport Obermeyer Ltd. Voluntarily Recalls Girls’ Jackets with Drawstrings at the Waist Due to Entrapment Hazard
The jackets have a drawstring at the waist which can pose an entrapment hazard to children.
admin | Mar 31, 2010
